Patient Perspectives on a Potential New Dermatomyositis Therapy: Exploring Insights from the Phase 3 VALOR Trial

Join Dr. Prateek Gandiga, a leading expert in dermatomyositis (DM), for a discussion on patient experiences in the VALOR trial, the largest study ever conducted for adults with DM. Explore what patients reported with an investigational once-daily oral medication about their symptoms, daily activities, quality of life, and overall well-being. Understand what these findings may mean for patients with DM and why patient-focused research is so important to advancing care for this condition. Thank you to our sponsor Priovant Therapeutics.

Register Here